March 1, 2022
Ms. Nudrat Salik
Office of Life Sciences
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: | SEC Comment Letter dated February 25, 2022 | ||
The Clorox Company | |||
Form 10-K for the Fiscal Year Ended June 30, 2021 | |||
Form 10-Q for the Period Ended December 31, 2021 | |||
Form 8-K Filed February 3, 2022 | |||
File No. 001-07151 |
Dear Ms. Salik:
We hereby acknowledge receipt of the above referenced letter. Per your discussion with Laura Peck, Vice President – Chief Accounting Officer & Corporate Controller, on February 28, 2022, we hereby confirm that we will respond to the above referenced letter on or before March 18, 2022. If you have any questions or need any additional information, please contact me at (510) 271-6572 or jinho.joo@clorox.com.
Sincerely, | ||
/s/ Jinho Joo | ||
Jinho Joo | ||
Senior Director |
cc: | ||
Kevin Jacobsen | Executive Vice President – Chief Financial Officer | |
Angela Hilt | Senior Vice President – Chief Legal Officer | |
Laura Peck | Vice President – Chief Accounting Officer & Corporate Controller |